PediRISE Feasibility

Description

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Conditions

Pediatric Cancer, Financial Stress, Financial Hardship, Disparities

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Pilot Randomized Pediatric RISE (Resource Intervention to Support Equity) Feasibility Study

PediRISE Feasibility

Condition
Pediatric Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Boston Children's Hospital, Boston, Massachusetts, United States, 02215

Boston

Dana Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Child diagnosed with de novo cancer
  • * Child has established care at a study site and initiated cancer-directed therapy in the prior 2-months
  • * Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan
  • * Child is \<18 years at time of enrollment
  • * Parent/guardian screened positive for self-reported low-income (\<200% FPL).
  • * Family primary residence in MA, NY or NJ
  • * Provider approval for permission to approach
  • * Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy
  • * Foreign national family receiving care as an Embassy-pay patient
  • * Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, AHOD2131, ANBL2131, DFCI 23-001).
  • * Child or household member receiving SSI.

Ages Eligible for Study

to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Kira Bona, MD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2024-12-31